72 related articles for article (PubMed ID: 11026306)
1. [Serotonin in cardiovascular disease].
Takata M; Tomoda F
Nihon Rinsho; 2000 Jan; 58 Suppl 1():432-5. PubMed ID: 11026306
[No Abstract] [Full Text] [Related]
2. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
3. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs.
Robertson JI
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S48-53. PubMed ID: 1717773
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and preactivated platelets in essential hypertension.
Bühler FR; Amstein R; Fetkovska N
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxytryptamine and vascular disease.
Vanhoutte PM
Fed Proc; 1983 Feb; 42(2):233-7. PubMed ID: 6822294
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and platelet activation during treatment with isradipine.
Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
[TBL] [Abstract][Full Text] [Related]
8. Platelet serotonin-LDL interaction in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S35-40. PubMed ID: 1717771
[TBL] [Abstract][Full Text] [Related]
9. Serotonin levels in hypertension.
Biondi ML; Agostoni A; Marasini B
J Hypertens Suppl; 1986 Apr; 4(1):S39-41. PubMed ID: 3457903
[TBL] [Abstract][Full Text] [Related]
10. [Serotonin and cardiovascular diseases].
Reneman RS; Wenting GJ
Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2080-4. PubMed ID: 7477565
[No Abstract] [Full Text] [Related]
11. Symposium on serotonin and cardiovascular regulation: a new approach to hypertension. Satellite symposium of the Second European Meeting on Hypertension. 9 June 1985, Milan, Italy.
J Hypertens Suppl; 1986 Apr; 4(1):S1-111. PubMed ID: 2939207
[No Abstract] [Full Text] [Related]
12. Serotonin metabolism and platelet aggregation under antihypertensive treatment with nitrendipine.
Sebeková K; Raucinová M; Sedláková K; Dzúrik R
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S161-3. PubMed ID: 2468865
[TBL] [Abstract][Full Text] [Related]
13. [Changes in serotoninergic mechanisms in essential hypertension].
Marazziti D; Falcone MF; Rosa C; Ghione S
Ann Ital Med Int; 1990; 5(4 Pt 2):459-63. PubMed ID: 2102132
[TBL] [Abstract][Full Text] [Related]
14. [Platelet aggregation in whole blood with the impedance method in subjects with non-complicated essential arterial hypertension].
Craveri A; Lanfredini M; Casati R; Citella C
Minerva Med; 1988 Jun; 79(6):441-6. PubMed ID: 2967926
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.
Suehiro A; Sawada A; Hasegawa Y; Takatsuka H; Higasa S; Kakishita E
Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation, platelet serotonin and pancreatitis.
Lechin F; van der Dijs B
JOP; 2004 Jul; 5(4):237-8; author reply 238-9. PubMed ID: 15254355
[No Abstract] [Full Text] [Related]
17. Platelet aggregation patterns in normotensive and hypertensive subjects.
Gupta S; Gupta VK; Dhamija RK; Kela AK
Indian J Physiol Pharmacol; 2002 Jul; 46(3):379-82. PubMed ID: 12613406
[No Abstract] [Full Text] [Related]
18. Serotonin, hypertension and vascular disease.
Vanhoutte PM
Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
[TBL] [Abstract][Full Text] [Related]
19. [Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
Lüscher TF; Tanner FC; Bühler FR
Dtsch Med Wochenschr; 1992 Apr; 117(18):710-9. PubMed ID: 1572260
[No Abstract] [Full Text] [Related]
20. Propranolol modifies platelet serotonergic mechanisms in rats.
Zółtowski R; Pawlak R; Matys T; Pietraszek M; Buczko W
J Physiol Pharmacol; 2002 Jun; 53(2):265-74. PubMed ID: 12120901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
